Cluster_ID,Ground_Truth,Ground_Truth_Label,Ground_Truth_Keywords,Standard_Genes,Standard_Answer,Standard_CellType,Standard_Confidence,Standard_Reasoning,Curated_Genes,Curated_Answer,Curated_CellType,Curated_Confidence,Curated_Reasoning,SingleR_Answer,Azimuth_Answer,CellTypist_Answer,GT_Major,GT_State,UsedInConfusion,Score_Standard,Score_Curated,Score_CellTypist,Score_SingleR,Score_Azimuth
CAFs MSC iCAF-like,Fibro_iCAF,Fibro_iCAF,"CXCL12, CFD, C7, IL6",DCN;APOD;LUM;FTL;C1S;MFAP4;CTSK;FBLN1;SERPINF1;RARRES2;CXCL12;TMEM176B;PTGDS;CCDC80;LRP1;SFRP2;TMEM176A;SEPP1;MEG3;SERPING1;C3;IGF1;ISLR;SRPX;MXRA8;CFD;FGF7;SPON2;MGP;LGALS3;C1R;EFEMP1;COL6A3;COL1A2;OLFML3;PDGFRL;PLTP;COL1A1;COL6A2;IGFBP6;FTH1;ZFP36L2;PSAP;PDGFRA;PRNP;MMP2;LSP1;MDK;CXCL14;EGR1,PDGFRA+ Fibroblast,PDGFRA+ Fibroblast,High,"The gene list is dominated by the canonical fibroblast marker PDGFRA, numerous genes for extracellular matrix components (e.g., COL1A1, COL1A2, DCN, LUM), and secreted factors characteristic of fibroblasts (e.g., CXCL12, FGF7).",DCN;APOD;LUM;C1S;MFAP4;CTSK;FBLN1;RARRES2;PTGDS;CCDC80;SFRP2;MEG3;C3;IGF1;ISLR;MXRA8;CFD;FGF7;SPON2;MGP;EFEMP1;COL6A3;COL1A2;COL1A1;IGFBP6;PDGFRA;CXCL14;TIMP1;ABCA6;MAFB;COL3A1;DPT;GEM;APOE;GPC3;ALDH1A1;SOD2;VCAN;CYP1B1;ABCA8;ITM2A;FIGF;RASD1;CYR61;FBLN2;OGN;CPXM1;CRABP2;CTGF;HTRA1,Lipofibroblast,Lipofibroblast,High,"The gene list shows strong co-expression of canonical fibroblast markers (PDGFRA, DCN, LUM, COL1A1, COL3A1) with a distinct set of genes involved in lipid metabolism and adipogenesis (APOD, PTGDS, RARRES2, APOE).",Fibroblasts,Fibroblast lineage,Peribronchial fibroblasts,Fibroblast,iCAF,True,0.3,1.0,0.3,0.3,0.3
CAFs myCAF-like,Fibro_myCAF,Fibro_myCAF,"ACTA2, TAGLN, MMP11, COL1A1",COL1A1;COL1A2;COL3A1;LUM;POSTN;COL6A3;SFRP2;VCAN;COL5A2;DCN;FN1;COL6A1;AEBP1;CTSK;CTHRC1;COL5A1;LGALS1;COL6A2;SPARC;ISLR;MFAP2;THBS2;MXRA8;RARRES2;MMP2;CCDC80;C1S;BGN;TIMP2;CDH11;MXRA5;FBLN1;THY1;LRP1;SPON2;CERCAM;COL12A1;FSTL1;RCN3;CD99;FBN1;PCOLCE;ADAM12;MMP14;PPIC;COL8A1;MDK;ASPN;FAP;SERPINF1,Activated fibroblast,Activated fibroblast,High,"The gene list is overwhelmingly dominated by markers of active extracellular matrix (ECM) production and remodeling. This includes numerous collagens (COL1A1, COL1A2, COL3A1), proteoglycans (LUM, DCN, VCAN), and key fibroblast activation markers such as POSTN, FAP, and CTHRC1.",COL1A1;COL1A2;COL3A1;LUM;POSTN;COL6A3;SFRP2;VCAN;DCN;FN1;CTSK;CTHRC1;COL5A1;ISLR;MFAP2;THBS2;MXRA8;RARRES2;CCDC80;C1S;FBLN1;SPON2;COL12A1;COL8A1;ASPN;CTGF;COL10A1;FBLN2;TIMP1;COL16A1;DPT;MEG3;HTRA1;MFAP5;MMP11;MRC2;MFAP4;ANTXR1;INHBA;SULF1;SFRP4;SDC1;HTRA3;CILP;TNFAIP6;IGF1;IGFBP6;NBL1;CXCL14;EFEMP1,Cancer-Associated Fibroblast,Cancer-Associated Fibroblast,High,"The gene list shows strong expression of canonical fibroblast markers (e.g., COL1A1, COL1A2, LUM, DCN, FN1) alongside a classic signature of activated, matrix-remodeling fibroblasts, including POSTN, CTGF, CTHRC1, and SFRP2, which are hallmarks of Cancer-Associated Fibroblasts (CAFs).",Fibroblasts,Fibroblast lineage,Peribronchial fibroblasts,Fibroblast,myCAF,True,1.0,0.3,0.3,0.3,0.3
Cycling PVL,Fibro_PVL,Fibro_PVL,"RGS5, MCAM, NOTCH3",TUBA1B;TYMS;STMN1;H2AFZ;HMGN2;TK1;TUBB;ACTA2;RPA3;RAN;KIAA0101;SLC25A5;RANBP1;CENPF;PFN1;PCNA;CKS2;LGALS1;HMGB1;BIRC5;SMC2;SDC2;NDUFA4L2;DTYMK;MAD2L1;DUT;UBE2T;GGH;PTTG1;CKS1B;TMEM106C;VPS29;LMNB1;H2AFV;MKI67;UBE2C;TIMP1;GAPDH;NUCKS1;MYL9;CENPW;MYLK;THY1;NAP1L1;TOP2A;LINC00152;SMC4;UQCC2;IDH2;HMGB2,Myofibroblast (proliferating),Myofibroblast (proliferating),High,"The gene list shows strong expression of myofibroblast and smooth muscle markers (ACTA2, MYL9, MYLK) and fibroblast markers (THY1). The list is also dominated by canonical cell cycle and proliferation markers (MKI67, PCNA, TOP2A, BIRC5), indicating a highly proliferative state.",STMN1;ACTA2;BIRC5;TIMP1;MYL9;TOP2A;LINC00152;UQCC2;CENPK;ENPEP;MIR4435-2HG;MAP3K7CL;RGS5;COL5A3;S1PR3;PHLDA2;MINOS1;TAGLN;EGFL6;COL1A1;CKLF;FN1;WFDC1;OR51E1;TNFAIP6;CNN1;ANTXR1;CCDC102B;NCAPG2;HIGD1A;DIAPH3;MCAM;AKAP12;COL1A2;RNF152;TRIP13;PLN;PPP1R14A;PDGFA;PHLDA1;NDUFA12;NDUFA13;NOTCH3;ITGA4;LYPD1;ATAD5;FAM204A;IFT43;KIF15;FADS1,Pericyte (proliferating),Pericyte (proliferating),High,"The cell expresses canonical pericyte markers (RGS5, NOTCH3, MCAM) alongside strong contractile/myofibroblast markers (ACTA2, TAGLN, MYL9) and fibroblast-associated collagen genes (COL1A1, COL1A2). The proliferating state is confirmed by numerous cell cycle genes (TOP2A, BIRC5, STMN1).",Fibroblasts,Smooth muscle,Smooth muscle,Fibroblast,PVL,True,0.3,1.0,1.0,0.3,1.0
Endothelial ACKR1,Endothelial,Endothelial,"PECAM1, VWF, CLDN5, ACKR1",ACKR1;CD74;VWF;HLA-DRA;HLA-DRB1;HLA-DPA1;PLVAP;AQP1;RAMP3;HLA-DRB5;PECAM1;DUSP23;PRCP;HLA-DPB1;ZNF385D;ENG;NPDC1;FKBP1A;HLA-DQB1;RNASE1;CLU;TGFBR2;PDLIM1;EMCN;ARL4A;HLA-DMA;CXorf36;CCL14;TM4SF1;TSPAN7;S100A10;ETS2;SNCG;HLA-E;IL33;ADGRL4;TPM3;SDCBP;ITGA6;CALCRL;CDC42EP3;EGFL7;SPRY1;MCTP1;HLA-DQA1;ADAM15;FXYD5;SELP;RAMP2;CYYR1,Antigen-presenting endothelial cell,Antigen-presenting endothelial cell,High,"The gene list shows a combination of canonical endothelial markers (e.g., VWF, PECAM1, PLVAP, ACKR1) and a strong, complete signature for MHC Class II antigen presentation (e.g., CD74, HLA-DRA, HLA-DRB1, HLA-DPA1, HLA-DPB1), which is characteristic of this specialized endothelial subtype.",ACKR1;CD74;VWF;HLA-DRA;HLA-DPA1;RAMP3;HLA-DRB5;PECAM1;PRCP;CLU;CCL14;TSPAN7;CALCRL;HLA-DQA1;SDPR;SELE;SLCO2A1;CD34;ITM2A;CLDN5;FAM167B;TMSB10;HYAL2;SCARB1;ADM5;RBP7;RCAN1;APLNR;STAB1;SPNS2;FLT1;IL6;CD320;C4orf32;CDH5;CD36;ICAM2;TEK;FABP4;SAT1;MMRN1;C7;CYTL1;CNTNAP3B;NRP2;SOD2;NOP10;CD79B;SCARF1;EDN1,Post-capillary Venular Endothelial Cell (Antigen-Presenting),Post-capillary Venular Endothelial Cell (Antigen-Presenting),High,"The cell expresses canonical endothelial markers (VWF, PECAM1, CDH5), specific post-capillary venule markers (ACKR1, SELE), and a strong antigen presentation signature through co-expression of multiple MHC class II genes (HLA-DRA, HLA-DPA1, HLA-DRB5, HLA-DQA1) and CD74.",Adipocytes,Blood vessels,EC venous systemic,Endothelial,Endothelial,True,1.0,1.0,1.0,0.15,1.0
Endothelial CXCL12,Endothelial,Endothelial,"PECAM1, VWF, CLDN5, ACKR1",SRGN;SRP14;RAMP2;TM4SF1;SLC9A3R2;CLEC14A;RNASE1;CLDN5;A2M;IFI27;ICAM2;PLPP1;IGFBP3;STMN1;HEY1;PECAM1;SAT1;PODXL;TMSB10;OCIAD2;SEMA3G;GNG11;CAV1;STOM;ESAM;NOTCH4;EGFL7;BST2;S1PR1;PALMD;NPDC1;CRIP2;EMCN;HLA-E;PTPRB;MMRN2;CDH5;CD93;CD9;CD74;PPA1;HLA-C;JAM2;SOX17;RHOB;ID1;MGST2;MECOM;HLA-DRB1;ARL15,Arterial endothelial cell,Arterial endothelial cell,High,"The gene list contains numerous canonical pan-endothelial markers (e.g., PECAM1, CDH5, CLDN5, ESAM) and key markers of arterial specification, including the transcription factor SOX17 and Notch signaling pathway components HEY1 and NOTCH4.",SLC9A3R2;CLDN5;ICAM2;PLPP1;IGFBP3;STMN1;HEY1;PECAM1;SAT1;PODXL;TMSB10;OCIAD2;SEMA3G;BST2;CDH5;CD74;FLT1;EFNA1;HYAL2;BTNL9;JAG2;CD34;RBP7;FABP4;EDN1;HLA-DRA;GJA5;PLLP;IGF2;CD320;TNFRSF4;HLA-DRB5;KLF2;C10orf10;STC1;ACE;PCSK5;DDIT4;INSR;LIMCH1;SOX18;ANXA3;HLA-DPA1;ALPL;TCF4;GATA2;ISG15;KDR;NOV;VWF,Arterial Endothelial Cell (ISG-high),Arterial Endothelial Cell (ISG-high),High,"Defined by canonical endothelial markers (PECAM1, CDH5, VWF), specific arterial markers (HEY1, GJA5, SOX18), and a strong interferon/activation signature including MHC-II genes (ISG15, HLA-DRA, CD74).",Adipocytes,Blood vessels,EC arterial,Endothelial,Endothelial,True,1.0,1.0,1.0,0.15,1.0
Endothelial RGS5,Endothelial,Endothelial,"PECAM1, VWF, CLDN5, ACKR1",PLVAP;RGCC;EGFL7;GNG11;HSPG2;ADGRL4;CALCRL;TM4SF18;VWF;RAMP2;RBP7;CCDC85B;CD34;CLEC14A;NOTCH4;FLT1;KDR;CRIP2;VWA1;AQP1;ARHGAP29;IVNS1ABP;RNASE1;COL15A1;RAMP3;PODXL;CXorf36;ROBO4;FSCN1;CDH5;PECAM1;EMCN;ITGA6;ESAM;APLNR;GMFG;COL4A2;SPRY1;EHD4;ENG;CD93;MGST2;FXYD5;FKBP1A;FAM167B;TNFRSF4;CALM1;TSPAN13;COL4A1;HLA-B,Endothelial cell,Endothelial cell,High,"The gene list is dominated by canonical pan-endothelial markers such as PECAM1 (CD31), CDH5 (VE-Cadherin), VWF, KDR (VEGFR2), and ENG (Endoglin), which are definitive for this lineage.",RGCC;CALCRL;TM4SF18;VWF;RBP7;CD34;FLT1;KDR;RAMP3;PODXL;CDH5;PECAM1;APLNR;FAM167B;TNFRSF4;BTNL9;SGK1;ICAM2;EFNA1;INSR;HYAL2;PCDH17;SLC9A3R2;CLDN5;CD74;CD36;SOX18;TP53I11;NRP2;CA2;TCF4;PLPP1;SCARF1;IL32;SCARB1;HECW2;ITM2A;TMSB10;CTNNB1;FAM101B;CD300LG;SDPR;CD320;HLA-DRA;STC1;PDGFB;HLA-DPA1;BST2;ADM;HLA-DRB5,Activated Endothelial cell,Activated Endothelial cell,High,"The cell expresses canonical endothelial markers (PECAM1, CDH5, VWF, KDR, CLDN5). The most prominent feature is the strong expression of MHC class II genes (HLA-DRA, HLA-DPA1, HLA-DRB5) and the associated invariant chain CD74, which are hallmarks of an activated, antigen-presenting state.",Adipocytes,Blood vessels,EC venous systemic,Endothelial,Endothelial,True,1.0,1.0,1.0,0.15,1.0
PVL Differentiated,Fibro_PVL,Fibro_PVL,"RGS5, MCAM, NOTCH3",MYL9;ACTA2;TAGLN;ADIRF;DSTN;TPM2;S100A4;SOD3;MFGE8;MYH11;NDUFA4L2;PLN;CSRP2;CRYAB;PHLDA2;TPM1;LBH;CALD1;TINAGL1;MCAM;PLAC9;RERGL;MYL6;MYLK;PPP1R14A;PTP4A3;NTRK2;NET1;MAP3K7CL;CALM2;NOTCH3;PTMA;MGST3;EFHD1;WFDC1;C1QTNF1;CSRP1;SEPT4;ACTB;GPRC5C;CASQ2;FRZB;AC013461.1;ISYNA1;SEPT7;LMOD1;MTHFD2;SORBS2;CRIP1;SPARCL1,Vascular Smooth Muscle Cell,Vascular Smooth Muscle Cell,High,"The gene list is dominated by canonical markers for the smooth muscle contractile apparatus, including ACTA2, TAGLN, MYH11, CALD1, and MYL9. The presence of NOTCH3 strongly indicates a vascular origin for these smooth muscle cells.",MYL9;ACTA2;TAGLN;MYH11;PLN;CSRP2;CRYAB;PHLDA2;MCAM;RERGL;PPP1R14A;PTP4A3;MAP3K7CL;NOTCH3;WFDC1;FRZB;LMOD1;SORBS2;CRIP1;IGFBP5;IGFBP7;GPX3;RGS5;MT1M;OR51E1;C11orf96;MT2A;ACTG2;PHLDA1;KCNMB1;TBX2-AS1;CNN1;C2orf40;PDGFA;HIGD1B;NFASC;SERPINI1;MT1A;MT1X;RASD1;COL14A1;ANGPTL4;SBSPON;SLC38A11;KCNA5;C12orf75;AVPR1A;EGFL6;NOL3;RRAD,Vascular Smooth Muscle Cell,Vascular Smooth Muscle Cell,High,"The gene list includes a canonical set of contractile smooth muscle markers (ACTA2, TAGLN, MYH11, CNN1) and markers associated with the vasculature (RGS5, NOTCH3), which is a classic signature for Vascular Smooth Muscle Cells.",Fibroblasts,Smooth muscle,Smooth muscle,Fibroblast,PVL,True,0.85,0.85,1.0,0.3,1.0
PVL Immature,Fibro_PVL,Fibro_PVL,"RGS5, MCAM, NOTCH3",RGS5;LHFP;NDUFA4L2;CPE;STEAP4;NOTCH3;KCNJ8;IGFBP7;CALD1;HIGD1B;COX4I2;PDGFRB;ABCC9;CCDC102B;EPS8;SEPT7;MYL9;MFGE8;FAM162B;TPM2;NR2F2;PCOLCE;ARHGDIB;SYNPO2;GGT5;COL18A1;MT2A;TPM1;MYO1B;SEPT4;SERPING1;ARHGAP15;PHLDA1;THY1;C20orf27;FRZB;TPPP3;SMOC2;SOD3;ZEB2;CD44;ACTA2;ISYNA1;TFPI;GJA4;CTSC;CHN1;APOE;CD63;FILIP1L,Pericyte,Pericyte,High,"The gene list contains a canonical set of pericyte markers, including RGS5, PDGFRB, and NOTCH3. The presence of contractile apparatus genes (ACTA2, MYL9, TPM2) and other mural cell markers (KCNJ8, ABCC9, CALD1) further solidifies this identification.",RGS5;STEAP4;NOTCH3;KCNJ8;IGFBP7;HIGD1B;CCDC102B;MYL9;MT2A;PHLDA1;FRZB;ACTA2;APOE;RGS16;ENPEP;TAGLN;TIMP1;PPP1R14A;CCL21;CCL2;COL1A2;COL3A1;GEM;CCL19;CST3;AVPR1A;RASD1;MCAM;C1S;C11orf96;CBR1;LINC00152;MIR4435-2HG;TDO2;GPX3;CD36;S1PR3;MT1A;ATP1B2;PDGFA;LPL;COL5A3;LZTS1;IGFBP5;MGP;RNF152;CRIP1;ANGPTL4;CRYAB;MT1M,Pericyte,Pericyte,High,"The gene list shows strong expression of canonical pericyte and vascular smooth muscle markers such as RGS5, NOTCH3, and KCNJ8, combined with contractile genes like ACTA2, TAGLN, and MYL9.",Fibroblasts,Smooth muscle,Smooth muscle,Fibroblast,PVL,True,1.0,1.0,1.0,0.3,1.0
